Concert: 2Q Earnings Snapshot
Aug. 02, 2018
LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $13.3 million in its second quarter.
The Lexington, Massachusetts-based company said it had a loss of 57 cents per share.
The biopharmaceutical company posted revenue of $2,000 in the period.
Concert shares have fallen 35 percent since the beginning of the year. The stock has risen 16 percent in the last 12 months.